Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema
| Үндсэн зохиолчид: | , , , , , , , , , , , , |
|---|---|
| Формат: | Conference item |
| Хэвлэсэн: |
American Thoracic Society
2019
|
| _version_ | 1826258091155390464 |
|---|---|
| author | Idell, S Beckert, L Brockway, B Simpson, G Southcott, A Lee, Y Rahman, N Light, R Shoemaker, S Gillies, J Komissarov, A Florova, G Sarva, K |
| author_facet | Idell, S Beckert, L Brockway, B Simpson, G Southcott, A Lee, Y Rahman, N Light, R Shoemaker, S Gillies, J Komissarov, A Florova, G Sarva, K |
| author_sort | Idell, S |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T18:28:32Z |
| format | Conference item |
| id | oxford-uuid:08d2a7ad-a84e-49d5-b8f7-901abc098763 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T18:28:32Z |
| publishDate | 2019 |
| publisher | American Thoracic Society |
| record_format | dspace |
| spelling | oxford-uuid:08d2a7ad-a84e-49d5-b8f7-901abc0987632022-03-26T09:14:59ZPhase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or EmpyemaConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:08d2a7ad-a84e-49d5-b8f7-901abc098763Symplectic Elements at OxfordAmerican Thoracic Society2019Idell, SBeckert, LBrockway, BSimpson, GSouthcott, ALee, YRahman, NLight, RShoemaker, SGillies, JKomissarov, AFlorova, GSarva, K |
| spellingShingle | Idell, S Beckert, L Brockway, B Simpson, G Southcott, A Lee, Y Rahman, N Light, R Shoemaker, S Gillies, J Komissarov, A Florova, G Sarva, K Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema |
| title | Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema |
| title_full | Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema |
| title_fullStr | Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema |
| title_full_unstemmed | Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema |
| title_short | Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema |
| title_sort | phase 1b trial of lti 01 single chain urokinase plasminogen activator scupa intrapleural fibrinolytic therapy ipft in patients with complicated parapneumonic effusions cpe or empyema |
| work_keys_str_mv | AT idells phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT beckertl phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT brockwayb phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT simpsong phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT southcotta phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT leey phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT rahmann phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT lightr phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT shoemakers phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT gilliesj phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT komissarova phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT florovag phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema AT sarvak phase1btrialoflti01singlechainurokinaseplasminogenactivatorscupaintrapleuralfibrinolytictherapyipftinpatientswithcomplicatedparapneumoniceffusionscpeorempyema |